— Know what they know.
Not Investment Advice

STEK OTC

Stemtech Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -88.9% 1Y: -99.2% 3Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $216929 mcap · 1.94B float · 1.44% daily turnover · Short 95% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range0.00001-0.0139
Volume50,000
Avg Volume27,935,119
Beta2.58
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOCharles S. Arnold
Employees1
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-11-26
4851 Tamiami Trail North
Naples, FL 34103
US
954 715 6000
About Stemtech Corporation

Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.

Recent Insider Trades

NameTypeSharesPriceDate
KAPLAN BENJAMIN NATH S-Sale 1,000,000 $0.03 2025-06-23
ARNOLD CHARLES STUAR P-Purchase 25,000 $0.05 2024-07-26
Mindshare Holdings, S-Sale 25,000 $0.06 2024-04-19
Green Darryl V A-Award 1,254,818 $0.05 2023-08-08
Green Darryl V A-Award 2,408,818 $0.05 2023-06-12

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms